• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[制霉菌素和两性霉素B与聚乙烯吡咯烷酮在非水溶剂体系中的吸附复合物]

[Nystatin and amphotericin B sorption complexes with polyvinyl-pyrrolidone in nonaqueous solvent systems].

作者信息

Vaĭnshteĭn V A, Etingov E D, Naumchik G N

出版信息

Antibiotiki. 1976 Aug;21(8):679-85.

PMID:999248
Abstract

Complexes of polyenic antibiotics with polyvinylpyrrolidone (PVP) can be used for preparing effective pharmaceutical forms soluble in water and consisting of fine dispersions. Studies were carried out; they are of great importance for revealing the mechanism of polyen interaction with neutral polymers, as well as for development of the technological processes for production of the pharmaceutical forms. The sorption isoterms of PVP with the molecular weight of 10 000 and 35 000 on nystatin and amphotericin B were obtained in the process of precipitation in the system of dimethylformamide-ethylacetate. The constants of the strength of the antibiotic binding with the polymer in a complex were calculated. It was shown that the complex strength increased with a rise in the relative amount of the precipitant in the system. The temperature dependence of the binding strength constant was studied. The process of the complex forming was shown to be exothermic, the activation energy of the complex being 26-30 kcal per a mole of the antibiotic. No significant differences in the binding strength of nystatin and amphotericin B were observed. On the basis of the experimental data, a scheme of the complex structure explaining the binding process by formation of a number of hydrogen bonds between the antibiotic hydroxyl groups and the PVP tertiaryamide groups is proposed.

摘要

多烯抗生素与聚乙烯吡咯烷酮(PVP)的复合物可用于制备可溶于水且由精细分散体组成的有效药物剂型。已开展相关研究;这些研究对于揭示多烯与中性聚合物的相互作用机制以及药物剂型生产工艺的开发具有重要意义。在二甲基甲酰胺 - 乙酸乙酯体系中沉淀过程中,获得了分子量为10000和35000的PVP在制霉菌素和两性霉素B上的吸附等温线。计算了复合物中抗生素与聚合物结合强度的常数。结果表明,复合物强度随体系中沉淀剂相对量的增加而增大。研究了结合强度常数的温度依赖性。复合物形成过程显示为放热过程,每摩尔抗生素的复合物活化能为26 - 30千卡。未观察到制霉菌素和两性霉素B结合强度的显著差异。基于实验数据,提出了一种复合物结构示意图,通过抗生素羟基与PVP叔酰胺基团之间形成多个氢键来解释结合过程。

相似文献

1
[Nystatin and amphotericin B sorption complexes with polyvinyl-pyrrolidone in nonaqueous solvent systems].[制霉菌素和两性霉素B与聚乙烯吡咯烷酮在非水溶剂体系中的吸附复合物]
Antibiotiki. 1976 Aug;21(8):679-85.
2
[Study of the association of nystatin and amphotericin B in nonaqueous solvent systems].[制霉菌素与两性霉素B在非水溶剂体系中的关联研究]
Antibiotiki. 1975 Aug;20(8):688-92.
3
Nystatin- and amphotericin B-induced structural alterations of the erythrocyte membrane: importance of reduced ionic strength.制霉菌素和两性霉素B诱导的红细胞膜结构改变:降低离子强度的重要性。
Exp Pathol. 1983;24(2-3):163-6. doi: 10.1016/s0232-1513(83)80028-0.
4
[Changes in ATPase activity of dog kidney nuclear membrane under the effect of polyenic antibiotics].
Biokhimiia. 1978 Jun;43(6):1019-23.
5
[Action of polyene antibiotics on ribosome binding with Candida albicans membranes].
Antibiotiki. 1977 Aug;22(8):695-9.
6
[Acid-base properties of the polyene antibiotic nystatin].
Antibiotiki. 1981 Jun;26(6):427-31.
7
[Supersensitivity to levorin and amphotericin B in several Saccharomyces cerevisiae mutants resistant to nystatin].[几种对制霉菌素耐药的酿酒酵母突变体对左菌素和两性霉素B的超敏反应]
Genetika. 1977;13(12):2221-4.
8
Factors influencing the susceptibility of Candida albicans to the polyenoic antibiotics nystatin and amphotericin B.
J Gen Microbiol. 1978 Feb;104(2):325-33. doi: 10.1099/00221287-104-2-325.
9
Interaction of amphotericin B and 43 degrees hyperthermia.
Cancer Res. 1977 Mar;37(3):761-4.
10
Two mutants selectively resistant to polyenes reveal distinct mechanisms of antifungal activity by nystatin and amphotericin B.两个对多烯类药物具有选择性抗性的突变体揭示了制霉菌素和两性霉素B不同的抗真菌活性机制。
Biochem Soc Trans. 2005 Nov;33(Pt 5):1206-9. doi: 10.1042/BST20051206.